1
|
Hu X, Liu T, Zhang Z, Xiao X, Chen L, Wei G, Wang Y, Yang K, Jin H, Zhu Y. Standalone ultrasound-based highly visualized volumetric spine imaging for surgical navigation. Sci Rep 2025; 15:4922. [PMID: 39929969 PMCID: PMC11810997 DOI: 10.1038/s41598-025-89440-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2024] [Accepted: 02/05/2025] [Indexed: 02/13/2025] Open
Abstract
Current navigation systems employing intraoperative CT have been applied in spinal interventions for accurate and visualized guidance. The consequential issue of radiation doses and surgical workflow disruption spotlighted ultrasound (US) as an alternative imaging modality. However, the challenge of anatomy interpretation left US-based navigation inadequate in visualization, resulting in the necessity of registration of preoperative images. Here we report a standalone ultrasound image-guided system (SUIGS) leveraging a purpose-made network to automatically extract bone features and reconstruct them into highly visualized volumetric images for spinal navigation. We showed the SUIGS highly visualized the bone markers with an imaging accuracy of 1.19 ± 0.85 mm in scanning tests on human volunteers. Through extensive testing on data from hospitalized patients containing atypical cases (spinal deformity, obesity), we confirmed that SUIGS generalizes across different individuals with a 100% success rate in aligning with preoperative CT. Furthermore, SUIGS yielded comparable results to three-dimensional fluoroscopy guidance in intraoperative intraspinal tumor localization and reduced the procedure to 8 min. This study explored and broadened the clinical application of standalone US navigation by providing intraoperative high-visualized volumetric spinal imaging, which is expected to increase the likelihood of surgeons adopting it in practice to reduce the occurrence of wrong-site surgery.
Collapse
Affiliation(s)
- Xinben Hu
- Department of Radiation Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, China.
| | - Tianjian Liu
- Department of Neurosurgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
- Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, China
| | - Zhengyuan Zhang
- School of Electrical and Electronic Engineering, Nanyang Technological University, Singapore, Singapore
| | - Xuan Xiao
- Department of Mechanical Engineering, Zhejiang University, Hangzhou, China
- State Key Laboratory of Fluid Power and Mechatronic Systems, Zhejiang University, Hangzhou, China
| | - Lin Chen
- Department of Mechanical Engineering, Zhejiang University, Hangzhou, China
- State Key Laboratory of Fluid Power and Mechatronic Systems, Zhejiang University, Hangzhou, China
| | - Gao Wei
- Department of Neurosurgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
- Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, China
| | - Yunjiang Wang
- Department of Mechanical Engineering, Zhejiang University, Hangzhou, China
- State Key Laboratory of Fluid Power and Mechatronic Systems, Zhejiang University, Hangzhou, China
| | - Keji Yang
- Department of Mechanical Engineering, Zhejiang University, Hangzhou, China
- State Key Laboratory of Fluid Power and Mechatronic Systems, Zhejiang University, Hangzhou, China
| | - Haoran Jin
- Department of Mechanical Engineering, Zhejiang University, Hangzhou, China.
- State Key Laboratory of Fluid Power and Mechatronic Systems, Zhejiang University, Hangzhou, China.
| | - Yongjian Zhu
- Department of Neurosurgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, China.
| |
Collapse
|
2
|
Guillemin PC, M’Rad Y, Dipasquale G, Lorton O, Fleury V, Momjian S, Borich A, Crowe LA, Zilli T, Boudabbous S, Salomir R. Using the Tissue Impulse Response Function to Streamline Fractionated MRgFUS-Induced Hyperthermia. Cancers (Basel) 2025; 17:515. [PMID: 39941882 PMCID: PMC11817472 DOI: 10.3390/cancers17030515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2024] [Revised: 01/27/2025] [Accepted: 01/31/2025] [Indexed: 02/16/2025] Open
Abstract
Background/Objectives: Combining radiation therapy with mild hyperthermia, especially via magnetic resonance-guided focused ultrasound (MRgFUS), holds promise for enhancing tumor control and alleviating symptoms in cancer patients. However, current clinical applications of MRgFUS focus primarily on ablative treatments, and using MRI guidance for each radiation session increases treatment costs and logistical demands. This study aimed to test a streamlined workflow for repeated hyperthermia treatments that reduces the need for continuous MRI monitoring, using an approach based on impulse response function (Green's function) to optimize acoustic power settings in advance. Methods: We implemented the Green's function approach in a perfused, tissue-mimicking phantom, conducting 30 experiments to simulate hyperthermia delivery via MRgFUS. Pre-calculated acoustic power settings were applied to maintain a stable hyperthermia target without the need for real-time feedback control from MRI thermometry. Additionally, a retrospective analysis of patient thermometry data from MRgFUS sonications was performed to assess feasibility in clinical contexts. Results: Our experiments demonstrated consistent, stable hyperthermia (+7 °C) for 15 min across varying perfusion rates, outperforming conventional closed-loop MRI feedback methods in maintaining temperature stability. The retrospective analysis confirmed that this method is noise-robust and clinically applicable. Conclusions: This off-line approach to hyperthermia control could simplify the integration of MRgFUS hyperthermia in cancer treatment, reducing costs and logistical barriers. These findings suggest that our method may enable the broader adoption of hyperthermia in radiation therapy, supporting its role as a viable adjuvant treatment in oncology.
Collapse
Affiliation(s)
- Pauline C. Guillemin
- Image Guided Interventions Laboratory, GR-949, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland; (Y.M.); (O.L.); (A.B.); (T.Z.); (S.B.); (R.S.)
| | - Yacine M’Rad
- Image Guided Interventions Laboratory, GR-949, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland; (Y.M.); (O.L.); (A.B.); (T.Z.); (S.B.); (R.S.)
| | | | - Orane Lorton
- Image Guided Interventions Laboratory, GR-949, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland; (Y.M.); (O.L.); (A.B.); (T.Z.); (S.B.); (R.S.)
- Clinical Neurosciences Department, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland; (V.F.); (S.M.)
| | - Vanessa Fleury
- Clinical Neurosciences Department, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland; (V.F.); (S.M.)
- Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
| | - Shahan Momjian
- Clinical Neurosciences Department, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland; (V.F.); (S.M.)
- Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
| | - Anna Borich
- Image Guided Interventions Laboratory, GR-949, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland; (Y.M.); (O.L.); (A.B.); (T.Z.); (S.B.); (R.S.)
| | - Lindsey A. Crowe
- Radiation Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, 6500 Bellinzona, Switzerland;
| | - Thomas Zilli
- Image Guided Interventions Laboratory, GR-949, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland; (Y.M.); (O.L.); (A.B.); (T.Z.); (S.B.); (R.S.)
- Radiation Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, 6500 Bellinzona, Switzerland;
- Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland
| | - Sana Boudabbous
- Image Guided Interventions Laboratory, GR-949, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland; (Y.M.); (O.L.); (A.B.); (T.Z.); (S.B.); (R.S.)
- Radiology Division, HUG, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland
| | - Rares Salomir
- Image Guided Interventions Laboratory, GR-949, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland; (Y.M.); (O.L.); (A.B.); (T.Z.); (S.B.); (R.S.)
- Radiology Division, HUG, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland
| |
Collapse
|
3
|
Lorton O, Guillemin PC, Peloso A, M’Rad Y, Crowe LA, Koessler T, Poletti PA, Boudabbous S, Ricoeur A, Salomir R. In Vivo Thermal Ablation of Deep Intrahepatic Targets Using a Super-Convergent MRgHIFU Applicator and a Pseudo-Tumor Model. Cancers (Basel) 2023; 15:3961. [PMID: 37568777 PMCID: PMC10417404 DOI: 10.3390/cancers15153961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 07/28/2023] [Accepted: 08/01/2023] [Indexed: 08/13/2023] Open
Abstract
BACKGROUND HIFU ablation of liver malignancies is particularly challenging due to respiratory motion, high tissue perfusion and the presence of the rib cage. Based on our previous development of a super-convergent phased-array transducer, we aimed to further investigate, in vivo, its applicability to deep intrahepatic targets. METHODS In a series of six pigs, a pseudo-tumor model was used as target, visible both on intra-operatory MRI and post-mortem gross pathology. The transcostal MRgHIFU ablation was prescribed coplanar with the pseudo-tumor, either axial or sagittal, but deliberately shifted 7 to 18 mm to the side. No specific means of protection of the ribs were implemented. Post-treatment MRI follow-up was performed at D7, followed by animal necropsy and gross pathology of the liver. RESULTS The pseudo-tumor was clearly identified on T1w MR imaging and subsequently allowed the MRgHIFU planning. The peak temperature at the focal point ranged from 58-87 °C. Gross pathology confirmed the presence of the pseudo-tumor and the well-delineated MRgHIFU ablation at the expected locations. CONCLUSIONS The specific design of the transducer enabled a reliable workflow. It demonstrated a good safety profile for in vivo transcostal MRgHIFU ablation of deep-liver targets, graded as challenging for standard surgery.
Collapse
Affiliation(s)
- Orane Lorton
- Image Guided Interventions Laboratory (GR-949), Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
| | - Pauline Coralie Guillemin
- Image Guided Interventions Laboratory (GR-949), Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
| | - Andrea Peloso
- Visceral Surgery Division, University Hospitals of Geneva, 1205 Geneva, Switzerland
| | - Yacine M’Rad
- Image Guided Interventions Laboratory (GR-949), Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
| | | | - Thibaud Koessler
- Oncology Department, University Hospitals of Geneva, 1205 Geneva, Switzerland
| | | | - Sana Boudabbous
- Image Guided Interventions Laboratory (GR-949), Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
- Radiology Division, University Hospitals of Geneva, 1205 Geneva, Switzerland
| | - Alexis Ricoeur
- Image Guided Interventions Laboratory (GR-949), Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
- Radiology Division, University Hospitals of Geneva, 1205 Geneva, Switzerland
| | - Rares Salomir
- Image Guided Interventions Laboratory (GR-949), Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland
- Radiology Division, University Hospitals of Geneva, 1205 Geneva, Switzerland
| |
Collapse
|
4
|
Nitinol thin films functionalized with CAR-T cells for the treatment of solid tumours. Nat Biomed Eng 2019; 4:195-206. [PMID: 31819155 DOI: 10.1038/s41551-019-0486-0] [Citation(s) in RCA: 69] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2018] [Accepted: 11/07/2019] [Indexed: 12/11/2022]
Abstract
Micropatterned nickel titanium (commonly known as nitinol) thin films with complex designs, high structural resolution and excellent biocompatibility can be cheaply fabricated using magnetron sputtering. Here, we show that these benefits can be leveraged to fabricate micromesh implants that are loaded with tumour-specific human chimeric antigen receptor (CAR)-T cells for the treatment of solid tumours. In a mouse model of non-resectable ovarian cancer, the cell-loaded nitinol thin films spatially conformed to the implantation site, fostered the rapid expansion of T cells, delivered a high density of T cells directly to the tumour and significantly improved animal survival. We also show that self-expandable stents that were coated with T-cell-loaded films and implanted into subcutaneous tumours in mice improved the duration of stent patency by delaying tumour ingrowth. By providing direct access to tumours, CAR-T-cell-loaded micropatterned nitinol thin films can improve the effects of cell-based therapies.
Collapse
|
5
|
Prediction of HIFU Propagation in a Dispersive Medium via Khokhlov–Zabolotskaya–Kuznetsov Model Combined with a Fractional Order Derivative. APPLIED SCIENCES-BASEL 2018. [DOI: 10.3390/app8040609] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
6
|
Celicanin Z, Manasseh G, Petrusca L, Scheffler K, Auboiroux V, Crowe LA, Hyacinthe JN, Natsuaki Y, Santini F, Becker CD, Terraz S, Bieri O, Salomir R. Hybrid ultrasound-MR guided HIFU treatment method with 3D motion compensation. Magn Reson Med 2017; 79:2511-2523. [PMID: 28944490 DOI: 10.1002/mrm.26897] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2017] [Revised: 08/10/2017] [Accepted: 08/11/2017] [Indexed: 01/16/2023]
Abstract
PURPOSE Treatments using high-intensity focused ultrasound (HIFU) in the abdominal region remain challenging as a result of respiratory organ motion. A novel method is described here to achieve 3D motion-compensated ultrasound (US) MR-guided HIFU therapy using simultaneous ultrasound and MRI. METHODS A truly hybrid US-MR-guided HIFU method was used to plan and control the treatment. Two-dimensional ultrasound was used in real time to enable tracking of the motion in the coronal plane, whereas an MR pencil-beam navigator was used to detect anterior-posterior motion. Prospective motion compensation of proton resonance frequency shift (PRFS) thermometry and HIFU electronic beam steering were achieved. RESULTS The 3D prospective motion-corrected PRFS temperature maps showed reduced intrascan ghosting artifacts, a high signal-to-noise ratio, and low geometric distortion. The k-space data yielded a consistent temperature-dependent PRFS effect, matching the gold standard thermometry within approximately 1°C. The maximum in-plane temperature elevation ex vivo was improved by a factor of 2. Baseline thermometry acquired in volunteers indicated reduction of residual motion, together with an accuracy/precision of near-harmonic referenceless PRFS thermometry on the order of 0.5/1.0°C. CONCLUSIONS Hybrid US-MR-guided HIFU ablation with 3D motion compensation was demonstrated ex vivo together with a stable referenceless PRFS thermometry baseline in healthy volunteer liver acquisitions. Magn Reson Med 79:2511-2523, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Collapse
Affiliation(s)
- Zarko Celicanin
- Department of Radiology, Division of Radiological Physics, University of Basel Hospital, Basel, Switzerland.,Department of Biomedical Engineering, University of Basel, Basel, Switzerland
| | - Gibran Manasseh
- Image Guided Interventions Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Lorena Petrusca
- Hepatobiliary and Pancreatic Interventional Radiology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Klaus Scheffler
- MRC Department, MPI for Biological Cybernetics, Tübingen, Germany.,Department of Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany
| | - Vincent Auboiroux
- Image Guided Interventions Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland.,Clinatec/LETI/CEA, 38054, Grenoble, France
| | - Lindsey A Crowe
- Radiology Department, University Hospitals of Geneva, Geneva, Switzerland
| | - Jean-Noel Hyacinthe
- Image Guided Interventions Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland.,School of Health Sciences, HES-SO, University of Applied Sciences and Arts of Western Switzerland, Geneva, Switzerland
| | | | - Francesco Santini
- Department of Radiology, Division of Radiological Physics, University of Basel Hospital, Basel, Switzerland.,Department of Biomedical Engineering, University of Basel, Basel, Switzerland
| | - Christoph D Becker
- Hepatobiliary and Pancreatic Interventional Radiology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.,Radiology Department, University Hospitals of Geneva, Geneva, Switzerland
| | - Sylvain Terraz
- Image Guided Interventions Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland.,Radiology Department, University Hospitals of Geneva, Geneva, Switzerland
| | - Oliver Bieri
- Department of Radiology, Division of Radiological Physics, University of Basel Hospital, Basel, Switzerland.,Department of Biomedical Engineering, University of Basel, Basel, Switzerland
| | - Rares Salomir
- Image Guided Interventions Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland.,Radiology Department, University Hospitals of Geneva, Geneva, Switzerland
| |
Collapse
|
7
|
Pashaie B, Hobbenaghi R, Malekinejad H. Anti-atherosclerotic effect of Cynodon dactylon extract on experimentally induced hypercholesterolemia in rats. VETERINARY RESEARCH FORUM : AN INTERNATIONAL QUARTERLY JOURNAL 2017; 8:185-193. [PMID: 29085605 PMCID: PMC5653881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/23/2017] [Accepted: 04/19/2017] [Indexed: 11/15/2022]
Abstract
Cynodon dactylon (Bermuda grass) is a perennial plant traditionally used as an herbal medicine in many countries. In the present study, anti-atherosclerotic property of ethanolic extract of C. dactylon was investigated in the experimentally induced hypercholesterolemia in rats. In this study, 36 male Wistar rats were selected and allocated into six groups (n = 6). The control group received a normal diet, sham group received a high cholesterol diet (HCD; 1.50% cholesterol and 24.00% fat) and other groups received a HCD and ethanolic extract of C. dactylon at low (100 mg kg-1), moderate (200 mg kg-1) and maximum (400 mg kg-1) doses via gavages. The last group received atorvastatin (10 mg kg-1) through gavage with a HCD. The study period for all groups was six months. At the end of this period, parameters including total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were assessed in the blood samples. Additionally, histopathological and immunohistochemical examinations on coronary and aorta arteries sections were performed. The results showed an increase in vessels wall thickness and proliferation of smooth muscle cells in the HCD group, while these pathological changes were not seen in C. dactylon-treated groups. Treatment of HCD animals with C. dactylon positively changed lipid profile by lowering of TC, TG and LDL-C. The results indicate that C. dactylon prevents from early atherosclerotic changes in the vessels wall.
Collapse
Affiliation(s)
- Belal Pashaie
- Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
| | - Rahim Hobbenaghi
- Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran;,Correspondence: Rahim Hobbenaghi. DVM, DVSc, Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran. E-mail:
| | - Hassan Malekinejad
- Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran;,Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran
| |
Collapse
|